https://www.selleckchem.com/pr....oducts/alantolactone
© 2020 Scorcia et al.Purpose The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant is approved in the United Arab Emirates (UAE) for treating diabetic macular edema (DME) in patients previously treated with a course of corticosteroids and that did not have a clinically significant rise in intraocular pressure (IOP). This ongoing study is assessing its effectiveness and safety in pseudophakic patients with DME in clinical practice from a single center in the UAE. Methods A retrospective, ongoing 6-month audit study (NCT0359
Like
Comment
Share
